RxSight, Inc. (RXST): Capital Expenditures
$3.83M
Year ended 2025-12-31
$4.43M
Trailing 12 months to 2026-06-30
+17.0%
3-year compound annual growth
+8.6%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.83M | -29.6% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $5.44M | +13.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $4.81M | +101.2% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $2.39M | +23.4% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $1.94M | -23.6% | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | $2.54M | n/a | 2022-03-08, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| RxSight, Inc. (RXST) | 2025-12-31 | $3.83M | -29.6% |
| Staar Surgical Co (STAA) | 2026-01-02 | $5.82M | -75.1% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $67.05M | +4.7% |
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $72.84M | -23.7% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $362.40M | -14.0% |
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $349.00M | +19.9% |
| Innovative Eyewear Inc (LUCYW) | 2025-12-31 | $72.5K | +16.6% |
Compare RXST, STAA, WRBY, EYE side by side · Screen every company in Ophthalmic Goods ↗